Table 3.

Significance of the dysglycemias variables comparison between COVID-19 and non-COVID-19, restricted by corticosteroids’ use or no use

Variables	Use of corticosteroids	No use of corticosteroids
	p value (COVID-19 vs. non-COVID-19)	p value (COVID-19 vs. non-COVID-19)
Highest glucose level at ICU admission	0.157*	0.967*
Highest glucose level during ICU stay	0.151#	0.234#
Mean glucose level during ICU stay	0.203#	0.741#
Mean glucose variability (CV %) during ICU stay	0.793†	0.078†
% of days with hyperglycemia (≥ 180 mg/dL)	0.713§	0.277§

*Wald test p value of the multivariate log-linear regression models adjusted for sex, history of diabetes, presumed obesity, age, APACHE II scores, SOFA scores in the first 24 h, and CRP levels in the first 24 h

^#Wald test p value of the multivariate log-linear regression models adjusted for history of diabetes, presumed obesity, age, APACHE II scores, Nosocomial infection, Mean SOFA during ICU stay, Mean CRP during ICU stay

^†Wald test p value of the multivariate linear regression models adjusted for sex, history of diabetes, age, APACHE II scores, Nosocomial infection, Mean SOFA during ICU stay, Mean CRP during ICU stay

^§Wald test p value of the multivariate linear regression models adjusted for sex, history of diabetes, presumed obesity, age, APACHE II scores, Nosocomial infection, Mean SOFA during ICU stay, Mean CRP during ICU stay